Literature DB >> 533287

Lymphocyte response to phytohemagglutinin in atopic dermatitis.

S T Elliott, J M Hanifin.   

Abstract

Studies of patients with atopic dermatitis (AD) have demonstrated several clinical and laboratory indications of immunity defects, but with frequently contradictory results. We have recently shown that many patients with negative cutaneous delayed type hypersensitivity to candidin and streptokinase-streptodornase may have normal in vitro lymphocyte transformation to the same antigens. We hypothesized that this represents recovery of immunocompetent cells when they are isolated in vitro. This report describes phytohemagglutinin-induced transformation of lymphocytes immediately after isolation and after four days in culture (precultured). Responses of lymphocytes from patients with AD were initially subnormal, but increased to normal levels after the preculture period. Our results suggest that defective immune function in AD is not due to a permanent intrinsic lymphocyte defect, but is more likely due to factors associated with disease activity and severity.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 533287

Source DB:  PubMed          Journal:  Arch Dermatol        ISSN: 0003-987X


  4 in total

Review 1.  The spectrum of cutaneous patch-test reactions in patients with atopic dermatitis.

Authors:  J M Hanifin; P A Klas
Journal:  Clin Rev Allergy Immunol       Date:  1996       Impact factor: 8.667

2.  Depressed lymphocyte transformation and the role of prostaglandins in atopic dermatitis.

Authors:  T Jakob; B N Huspith; Y E Latchman; R Rycroft; J Brostoff
Journal:  Clin Exp Immunol       Date:  1990-03       Impact factor: 4.330

Review 3.  Immunoregulatory abnormalities in atopic dermatitis.

Authors:  D Y Leung; R S Geha
Journal:  Clin Rev Allergy       Date:  1986-02

4.  Decreased natural killer cell activity in atopic eczema.

Authors:  T J Hall; R Rycroft; J Brostoff
Journal:  Immunology       Date:  1985-10       Impact factor: 7.397

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.